Skip to main content

Drug companies and doctors battle over the future of fecal transplants

By The New York Times  
   March 04, 2019

CAMBRIDGE, Mass. — There's a new war raging in health care, with hundreds of millions of dollars at stake and thousands of lives in the balance. The battle, pitting drug companies against doctors and patient advocates, is being fought over the unlikeliest of substances: human excrement.

Full story


Get the latest on healthcare leadership in your inbox.